Back
MarketAxess Holdings 10K Form
Sell
44
MKTX
MarketAxess Holdings
Last Price:
$229.36
Seasonality Move:
5.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | MKTX/MarketAxess Holdings Quarterly |
2023-10-25 | 10Q | MKTX/MarketAxess Holdings Quarterly |
2023-07-27 | 10Q | MKTX/MarketAxess Holdings Quarterly |
2023-04-27 | 10Q | MKTX/MarketAxess Holdings Quarterly |
2022-10-26 | 10Q | MKTX/MarketAxess Holdings Quarterly |
2022-07-27 | 10Q | MKTX/MarketAxess Holdings Quarterly |
Receive MKTX News And Ratings
See the #1 stock for the next 7 days that we like better than MKTX
MKTX Financial Statistics
Sales & Book Value
Annual Sales: | $752.5M |
---|---|
Cash Flow: | $82.9M |
Price / Cash Flow: | 29.67 |
Annual Sales: | $36.75 |
Price / Book: | 6.24 |
Profitability
EPS (TTM): | 7.38000 |
---|---|
Net Income (TTM): | $278.7M |
Gross Margin: | $545.6M |
Return on Equity: | 21.38% |
Return on Assets: | 14.82% |
MarketAxess Holdings Earnings Forecast
Key MarketAxess Holdings Financial Ratios
-
The Gross Profit Margin over the past 22 years for MKTX is 72.50%.
-
The Selling, General & Administrative Expenses for MKTX have been equal to 10.66% of Gross Profit Margin.
-
The Interest Expense is 0.77% of Operating Income.
-
The Net Earning history of MKTX is 34.29% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 16 years.
MarketAxess Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | MKTX |
CUSIP: | 57060D |
Website: | marketaxess.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.58 |
Quick Ratio: | 3.1 |
Price-to-Earnings
Trailing P/E Ratio: | 33.5 |
---|---|
Forward P/E Ratio: | 28.17 |
MKTX Technical Analysis vs Fundamental Analysis
Sell
44
MarketAxess Holdings (MKTX)
is a Sell
Is MarketAxess Holdings a Buy or a Sell?
-
MarketAxess Holdings stock is rated a SellThe current MarketAxess Holdings [MKTX] share price is $229.46. The Score for MKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.